Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
36.0%
% of FTXH's 51 holdings also in PBE
64.3%
% of PBE's 28 holdings also in FTXH
Overlap by Weight
Sector Drift (FTXH minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FTXH |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 3.9% | 5.3% | 3.9% |
|
AMGEN INC | 3.8% | 5.0% | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.8% | 4.5% | 3.8% |
|
BIOGEN IDEC INC | 3.6% | 4.7% | 3.6% |
|
REGENERON PHARMACEUTICALS | 3.4% | 4.4% | 3.4% |
Position Highlights (Non-Overlapping Exposures)
FTXH Overweight Relative to PBE
|
JOHNSON & JOHNSON | 8.1% |
|
MERCK & CO. INC. | 7.1% |
|
PFIZER INC | 7.1% |
|
ABBVIE INC | 7.0% |
|
BRISTOL-MYERS SQUIBB CO | 7.0% |
|
ELI LILLY & CO | 3.9% |
|
ZOETIS INC | 3.8% |
|
VIATRIS, INC. | 3.5% |
 |
JAZZ PHARMACEUTICALS PLC | 3.0% |
|
ORGANON & CO. | 2.3% |
FTXH Underweight Relative to PBE
|
NATERA INC | -5.4% |
|
PROTAGONIST THERAPEUTICS, INC. | -4.1% |
|
NEUROCRINE BIOSCIENCES INC | -3.6% |
|
TG THERAPEUTICS INC | -3.3% |
|
ROYALTY PHARMA PLC CLASS A | -3.0% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -2.9% |
|
BIOCRYST PHARMACEUTICALS INC | -2.7% |
|
ILLUMINA INC | -2.6% |
|
CAREDX, INC. | -2.6% |
|
CATALYST PHARMACEUTICAL PART | -2.6% |